← Leaderboards
Christopher Buck
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusVirionAntibodiesPolyomavirusMalignant NeoplasmsVaccine DevelopmentVaccinesPreventViralInfectionHuman PapillomavirusBaseSerumVirus-Like ParticleJc VirusBk VirusCapsid ProteinsAdultMolecular BiologyPolyomavirus InfectionsPapillomavirusMediatingSymptomsUrinary Tract
Grant awards (36)
BKV and JCV vaccine development$763,673
ZIA · FY2025 · CA · contact PI
Molecular biology of human polyomaviruses$763,673
ZIA · FY2025 · CA · contact PI
Molecular biology of human polyomaviruses$772,907
ZIA · FY2024 · CA · contact PI
BKV and JCV vaccine development$772,907
ZIA · FY2024 · CA · contact PI
Molecular biology of human polyomaviruses$771,566
ZIA · FY2023 · CA · contact PI
BKV and JCV vaccine development$771,566
ZIA · FY2023 · CA · contact PI
Molecular biology of human polyomaviruses$661,981
ZIA · FY2022 · CA · contact PI
BKV and JCV vaccine development$661,981
ZIA · FY2022 · CA · contact PI
Molecular biology of human polyomaviruses$448,512
ZIA · FY2021 · CA · contact PI
BKV and JCV vaccine development$448,512
ZIA · FY2021 · CA · contact PI
Molecular biology of human polyomaviruses$443,703
ZIA · FY2020 · CA · contact PI
BKV and JCV vaccine development$443,703
ZIA · FY2020 · CA · contact PI
BKV and JCV vaccine development$595,210
ZIA · FY2019 · CA · contact PI
Molecular biology of human polyomaviruses$595,210
ZIA · FY2019 · CA · contact PI
Molecular biology of human polyomaviruses$545,738
ZIA · FY2018 · CA · contact PI
BKV and JCV vaccine development$545,738
ZIA · FY2018 · CA · contact PI
BKV and JCV vaccine development$504,307
ZIA · FY2017 · CA · contact PI
Molecular biology of human polyomaviruses$504,307
ZIA · FY2017 · CA · contact PI
Molecular biology of human polyomaviruses$532,485
ZIA · FY2016 · CA · contact PI
BKV and JCV vaccine development$532,485
ZIA · FY2016 · CA · contact PI
BKV and JCV vaccine development$504,027
ZIA · FY2015 · CA · contact PI
Molecular biology of human polyomaviruses$504,027
ZIA · FY2015 · CA · contact PI
Molecular biology of human polyomaviruses$528,787
ZIA · FY2014 · CA · contact PI
BKV and JCV vaccine development$528,787
ZIA · FY2014 · CA · contact PI
BKV and JCV vaccine development$354,395
ZIA · FY2013 · CA · contact PI
Merkel Cell Carcinoma Polyomavirus$354,395
ZIA · FY2013 · CA · contact PI
Merkel Cell Carcinoma Polyomavirus$397,155
ZIA · FY2012 · CA · contact PI
BKV and JCV vaccine development$397,155
ZIA · FY2012 · CA · contact PI
Merkel Cell Carcinoma Polyomavirus$508,009
ZIA · FY2011 · CA · contact PI
Papillomavirus Infectious Entry$127,002
ZIA · FY2011 · CA · contact PI
Merkel Cell Carcinoma Polyomavirus$504,748
ZIA · FY2010 · CA · contact PI
Papillomavirus Infectious Entry$126,187
ZIA · FY2010 · CA · contact PI
Merkel Cell Carcinoma Polyomavirus$428,156
ZIA · FY2009 · CA · contact PI
Papillomavirus Infectious Entry$107,040
ZIA · FY2009 · CA · contact PI
Papillomavirus Infectious Entry$318,263
Z01 · FY2008 · CA · contact PI
Merkel Cell Carcinoma Polyomavirus$106,088
Z01 · FY2008 · CA · contact PI